Loren Glasser, MD; Pete Hiatt, MD; Jeffrey Whitsett, MD; Michael Knowles, MD; Beryl Rosenstein, MD

Topics covered in this program include: an overview of cystic fibrosis and discussion of new directions in therapy; respiratory viral infections; gene therapy; and the use of pulmonzyme in treatment of cystic fibrosis.

Jocelyn Hulbert; Rene Morrissey, RN, EMT-P; Gayle Jones, RN, BSN, MA; Bryna Helfer, MA

Identify 3 chronic conditions that lead increased risk for medical emergencies, find areas where prehospital or acute care providers can assist children with special health needs, benefits of early referral to physical medical and rehab programs.

Martin G. Hellman, MD, FAAP, FACEP; Lisa Deranek, MD; Jeffrey Ekstein, MD; David Uchlcin, RN

Most common poisons encountered in the pediatric population; Assess the pertinent information in the pre-hospital setting; Discuss the pertinent pre-hospital treatment modalities; Understand common signs and symptoms of lead poisoning; Recognize the pre-hospital provider's role in averting pediatric poisoning.

Loren M. Glasser, MD; Peter W. Hiatt, MD

Renowned physicians discussing new directions of therapy for pediatric Cystic Fibrosis and respiratory viral infections.